Flat Medical launches epidural safeguard ​EpiFaith® for Asia Pacific market

KUALA LUMPUR, Sept 22 -- Flat Medical Co Ltd, a MedTech company providing clinical safety solutions, has launched its flagship product, EpiFaith®, in the Asia Pacific market.

Following its United States and European launch announcement last year, the company has been devoted to supplying EpiFaith®, the visualised safety solution for epidural locating, to Western hospitals.

“Epidural is one of the most common procedures we do in our daily practice; most Asian anesthesiologists are good at performing it; colleagues here believe that they can do it easily with the current technique,” said National Taiwan University Hospital professor (Department of Anesthesiology), and medical consultant of Flat Medical’s advisory board, Dr Wei-Zen Sun.

“But the truth is it's not, PDPH and CNS injury in epidural is still a big problem, and, unfortunately, some colleagues chose to neglect the risk. We are happy that the product has finally been approved and launched here to eliminate the accidental dural puncture.”

According to a statement, during the recently held annual meeting of Taiwanese Society of Anesthesiologists, the company has announced its formal launch of EpiFaith® in the Asia Pacific market.

The company earns its first regulatory approval in Asia in the second quarter of 2020, from the Taiwanese FDA. It is also working with selected local partners in Australia, Japan, South Korea, India, and Vietnam to have EpiFaith® approved and launched in local markets.

-- BERNAMA